Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  SWAN Knowledge Base
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Research News
 
γ-Secretase Drives Spine Formation Via Novel Substrate
10 May 2009. The γ-secretase has come a long way since its original discovery as the protease responsible for the production of amyloid-β peptides during sequential cleavage of the amyloid precursor protein...
 
HAI Seattle: Aβ May Disrupt Brain Function in Normal Seniors
8 May 2009. Figuring out what high levels of brain amyloid mean for otherwise healthy older people was a prime focus of the Human Amyloid Imaging (HAI) conference...
 
Research Brief: Targeting Trinucleotide Repeats Tamps Toxic RNAs
8 May 2009. The stutter that causes an overabundance of DNA repeats in diseases such as Huntington’s is tricky to silence because the normal genes, too, have their own, smaller share of repeats...
 
News Brief: HBO’s Alzheimer’s Project Debuts on Mother’s Day
8 May 2009. For the past two years, HBO’s award-winning documentary team has been filming and editing a massive project on Alzheimer disease...
 
GO TO ALL RESEARCH NEWS  
 
 
In the spotlight

Seattle Hosts Latest and Greatest on Amyloid Imaging
Unseasonably blue skies graced the Rainy City as some 150 researchers gathered there 24 April for the 3rd annual Human Amyloid Imaging (HAI) conference. Do you want to know what amyloid in cognitively normal people really means? The definitive answer isn't in quite yet, but with 18 talks, 16 posters, and ample discussion, this one-day meeting featured new data relating brain amyloid load to a host of other Alzheimer disease biomarkers. Check this space for Esther Landhuis's stories.
Does Brain Amyloid Correlate With Sagging Metabolism?
Aβ May Disrupt Brain Function in Normal Seniors
Symposium: Therapeutics in Cognitive Aging
View larger image
This one-day symposium at the New York Academy of Sciences on 15 May 2009 will focus on an issue of great importance to an aging society—the development of novel therapies for cognitive decline across the lifespan of humans. This meeting will convene prominent basic and clinical scientists who study the cognitive and neurobiological aspects of aging and its consequences for cognition. For more information and to register, please visit website.
Coverage of the 9th International Conference AD/PD 2009
View larger image
The biannual meeting convened some 2,300 people from all over the world in the Czech capital city of Prague on March 11-15, immediately following symposia by researchers who are conducting collaborative projects funded by the European Commission. Much of Prague's beguiling beauty had not yet emerged from its winter slumber, but the conference made up for that with a rich program and was roundly considered well worth the trip.


Photo above: Prague's Old Town Square, with Gothic Tyn Cathedral in back. Image credit: Carmela Abraham
AD/PD Convenes Record Number of Youngsters and Leaders
What Say You, Alois—Should It Be “Alzheimer-Fischer” Disease?
N-terminal APP Story Buzzes in the Hallways
Tau-Laden Neurons in Zebrafish Glow Red, Perish on Candid Camera
Aβ Rehabilitated as an Antimicrobial Protein?
Piecing Together Pathology with PyroGlu

 
 
What's New

Jobs - Posted 10 May 2009
Scientist: Elan Pharmaceuticals, Inc., South San Francisco, California.
 
Jobs - Posted 7 May 2009
Brain Slice Electrophysiologist for Drug Discovery: Lundbeck Research USA, Paramus, New Jersey.
 
Conferences - Posted 7 May 2009
19th World Congress of Neurology: 24-30 October 2009, Bangkok, Thailand.
 
Comments - Posted 7 May 2009
Read remarks by Bart De Strooper, Luca Scorrano, Vanessa Morais about Morais V et al.
NEWS: That Touch of Pink1—Toning Mitochondrial Respiration
 
Conferences - Posted 6 May 2009
The Michael J. Fox Foundation: Third Annual Parkinson's Disease Therapeutics Conference: 30 September 2009, New York Academy of Sciences, New York, NY, U.S.A.
 
Comments - Posted 5 May 2009
Read remarks by Paul Coleman about Jacobson MW et al.
PAPER: The emergence of cognitive discrepancies in preclinical Alzheimer's disease: A six-year case study.
 
Comments - Posted 5 May 2009
Read remarks by Mikko Laakso about Klunk WE et al.
PAPER: Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
 
Comments - Posted 5 May 2009
Read remarks by Rudolf Bloechl about Bengoechea TG et al.
NEWS: Peripheral p75 Protects Against Aβ Toxicity

SEE MORE  
Print this page
Email this page
Alzforum News
Text size
Share & Bookmark
AlzRisk: An AD Epidemiology Database
The AlzRisk Epidemiology Database provides a publicly available collection of published studies on the impact of putative environmental risk factors and protective factors related to Alzheimer disease in longitudinal cohort studies.
AlzGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Forum Calendar

Topics in Neurodegeneration
Download Powerpoint Presentations created by top experts in neurodegenerative disease research. Available for educational or personal use. Edited by Daniel M. Michaelson, PhD, and Tobias Hartmann, PhD.

ISOA

The Drug Development Company Database and Tutorial represent the collaborative efforts of the Alzheimer's Drug Discovery Foundation (ADDF)/Institute for the Study on Aging (ISOA) and the Alzheimer Research Forum. Our thanks to ADDF, Jens Eckstein, and the Advisory Board for bringing this project to fruition.
ISOA
Polls
       
Better drug for AD being a ways off, what measure is most likely to help affected families now?
 
Innovative care models
 
Community-based care
 
More day care centers
 
More care for the carers
 
More AD psychosocial research
 
We are doing well on those fronts
 
Keep eye on ball: more drug trials
 
Other
 
 
 
 
 
Archived Polls
 
Copyright © 1996-2009 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad